localized eczema
Conditions
Interventions
Qing peng cream group:apply Qing peng cream, bid
Qingpeng ointment base:apply Qingpeng ointment base, bid
Sponsors
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. aged from 18-80 years male and female; 2. Clinically Diagnosed localized chronic eczema, Skin involvement for 1% to 15% of body surface areapatients; 3. The disease has no obvious cause; 4. Participant fully understands the content of the clinical trial, is willing to attend the research voluntary andsign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. allergic to the study drugs; 2. with severe disease in the liver, kidney, and/or blood; with autoimmune diseases, chronic serious infection, diabetes, mental diseases, substance abuse, and/or alcoholic; with the malignant tumor or other serious diseases that may compromise the accuracy of efficacy evaluation for the study drug; 3. apply corticosteroids cream within 2 weeks; have taken systemic corticosteroids or other systemic immune inhibitors (e.g. Tripterygium wilfordii et al.) within 4 weeks; 4. rash on face, skin folds such as anus, vulva; 5. Skin lesions with a total area of more than 15% of the body surface area or less than 1%; 6. other reasons that researchers think that should not be selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;EASI;Four-item itch questionnaire; | — |
Countries
China
Contacts
Public ContactXU WEI
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed